ibudilast has been researched along with Alcohol Drinking in 5 studies
Alcohol Drinking: Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we examined the ability of ibudilast, a non-selective phosphodiesterase inhibitor, to reduce alcohol drinking and relapse in alcohol-preferring P rats, high-alcohol drinking HAD1 rats, and in mice made dependent on alcohol through cycles of alcohol vapor exposure." | 7.81 | Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence. ( Becker, HC; Bell, RL; Cui, C; Egli, M; Franklin, KM; Johnson, KW; Lopez, MF, 2015) |
| "Ibudilast-treated participants had lower Cho in superior frontal white matter and nominally lower MI in pregenual anterior cingulate cortex." | 7.11 | Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial. ( Alger, J; Burnette, E; Evans, CJ; Grodin, EN; Irwin, MR; London, ED; Meredith, LR; Miotto, K; Nieto, SJ; O'Neill, J; Ray, LA, 2022) |
| " In this study, we examined the ability of ibudilast, a non-selective phosphodiesterase inhibitor, to reduce alcohol drinking and relapse in alcohol-preferring P rats, high-alcohol drinking HAD1 rats, and in mice made dependent on alcohol through cycles of alcohol vapor exposure." | 3.81 | Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence. ( Becker, HC; Bell, RL; Cui, C; Egli, M; Franklin, KM; Johnson, KW; Lopez, MF, 2015) |
| "Ibudilast-treated participants had lower Cho in superior frontal white matter and nominally lower MI in pregenual anterior cingulate cortex." | 3.11 | Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial. ( Alger, J; Burnette, E; Evans, CJ; Grodin, EN; Irwin, MR; London, ED; Meredith, LR; Miotto, K; Nieto, SJ; O'Neill, J; Ray, LA, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grodin, EN | 4 |
| Nieto, SJ | 1 |
| Meredith, LR | 2 |
| Burnette, E | 2 |
| O'Neill, J | 1 |
| Alger, J | 1 |
| London, ED | 1 |
| Miotto, K | 3 |
| Evans, CJ | 1 |
| Irwin, MR | 2 |
| Ray, LA | 4 |
| Green, R | 1 |
| Chorpita, M | 1 |
| Burnette, EM | 1 |
| Baskerville, WA | 1 |
| Bujarski, S | 1 |
| Towns, B | 1 |
| Nieto, S | 1 |
| Lim, A | 1 |
| Lin, J | 1 |
| Gillis, A | 1 |
| Evans, C | 1 |
| Bell, RL | 1 |
| Lopez, MF | 1 |
| Cui, C | 1 |
| Egli, M | 1 |
| Johnson, KW | 1 |
| Franklin, KM | 1 |
| Becker, HC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Development of Ibudilast as a Novel Treatment for Alcohol Dependence[NCT02025998] | Phase 1 | 24 participants (Actual) | Interventional | 2013-12-31 | Completed | ||
| A Randomized Controlled Clinical Trial of the Neuroimmune Modulator Ibudilast for the Treatment of Alcohol Use Disorder[NCT03594435] | Phase 2 | 102 participants (Actual) | Interventional | 2018-10-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for ibudilast and Alcohol Drinking
| Article | Year |
|---|---|
Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial.
Topics: Alcohol Drinking; Alcoholism; Animals; Aspartic Acid; C-Reactive Protein; Choline; Creatine; Humans; | 2022 |
Ibudilast moderates the effect of mood on alcohol craving during stress exposure.
Topics: Affect; Alcohol Drinking; Alcoholism; Craving; Ethanol; Humans; Indolizines; Pyrazoles; Pyridines | 2022 |
Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial.
Topics: Alcohol Drinking; Alcoholism; Clinical Trials, Phase II as Topic; Craving; Double-Blind Method; Fema | 2020 |
Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial.
Topics: Alcohol Drinking; Alcoholism; Craving; Cues; Humans; Magnetic Resonance Imaging; Pyridines | 2021 |
1 other study available for ibudilast and Alcohol Drinking
| Article | Year |
|---|---|
Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence.
Topics: Alcohol Drinking; Alcoholism; Animals; Behavior, Animal; Disease Models, Animal; Male; Mice; Phospho | 2015 |